
SOHO Brazil 2024
Videos
SOHO Brazil 2024
SOHO Brazil 2024: Treatment of Primary CNS Lymphoma
FEATURING
Alvaro Alencar
- 47 views
- July 12, 2024
SOHO Brazil 2024
Summary of Recent Updates in Advanced Hodgkin Lymphoma
FEATURING
Craig Moskowitz
- 129 views
- July 11, 2024
- 2
SOHO Brazil 2024
Where I Use Azacitidine and Venetoclax in AML: Present and Future
FEATURING
Jeffrey Lancet
- 225 views
- July 11, 2024
- 2
SOHO Brazil 2024
1L Therapy in CLL: What Are the Best Options?
FEATURING
Jan Burger
- 71 views
- July 11, 2024
SOHO Brazil 2024
Managing Infectious Complications With Bispecific and CAR-T Therapy in MM
FEATURING
Noopur S. Raje
- 111 views
- July 11, 2024
- 1
SOHO Brazil 2024
When to Consider Bispecific and CAR-T Therapy in MM
FEATURING
Noopur S. Raje
- 109 views
- July 11, 2024
SOHO Brazil 2024
Frontline MM: Are Four Better Than Three?
FEATURING
Noopur S. Raje
- 15 views
- July 11, 2024
SOHO Brazil 2024
To 2L and Beyond: Treatment Options in R/R MCL
FEATURING
Tycel Phillips
- 17 views
- July 11, 2024
SOHO Brazil 2024
FL Updates: Is There a Standard 1L Treatment?
FEATURING
Brad Kahl
- 22 views
- July 11, 2024
SOHO Brazil 2024
3L in CLL: The Best Options in a Patient Double-Refractory to Covalent BTKi and to BCL-2 Inhibitor
FEATURING
Jan Burger
- 22 views
- July 11, 2024
SOHO Brazil 2024
Single vs. Multiple Agents in 2L Therapy for CLL
FEATURING
Jan Burger
- 27 views
- July 11, 2024
SOHO Brazil 2024
Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde
FEATURING
Jeffrey Lancet
- 181 views
- July 11, 2024
SOHO Brazil 2024
Therapies on the Horizon in LR- and HR-MDS
FEATURING
Rami Komrokji
- 105 views
- July 11, 2024
SOHO Brazil 2024
What Is the Best Timing for Bispecific Antibodies and CAR-T Therapy in LBCL?
FEATURING
Andrew Zelenetz
- 27 views
- July 11, 2024
SOHO Brazil 2024
DLBCL Pts Ineligible for CAR-T Therapy: Do They Exist and How Do We Treat Them?
FEATURING
Andrew Zelenetz
- 58 views
- July 11, 2024
SOHO Brazil 2024
Summary of Updates in R/R DLBCL Treatment
FEATURING
Alvaro Alencar
- 45 views
- July 11, 2024
SOHO Brazil 2024
Has the 1L SoC Truly Changed in Advanced Stage DLBCL?
FEATURING
Andrew Zelenetz
- 211 views
- July 11, 2024
- 1
SOHO Brazil 2024
Summary of Recent Updates in R/R HL
FEATURING
Craig Moskowitz
- 49 views
- July 11, 2024
- 1
SOHO Brazil 2024
Summary of Recent Updates on LR-MDS Management
FEATURING
Rami Komrokji
- 18 views
- July 11, 2024
SOHO Brazil 2024
How Are Targeted Therapies Redefining the Treatment Paradigm in ALL in Adults
FEATURING
Jan Burger
- 28 views
- July 11, 2024
SOHO Brazil 2024
Early Stage HL: Can Radiation Therapy Be Eliminated?
FEATURING
Craig Moskowitz
- 57 views
- July 11, 2024
SOHO Brazil 2024
PNH: Summary of Latest Advancements and Case Discussion
FEATURING
Bruno Fattizzo
- 50 views
- July 11, 2024
SOHO Brazil 2024
The Gold Standard in the Use of FLT3 and IDH Inhibitors in AML
FEATURING
Jeffrey Lancet
- 93 views
- July 11, 2024
SOHO Brazil 2024
Making Sense of 1L Treatment Options in MCL
FEATURING
Tycel Phillips
- 86 views
- July 11, 2024